Canada Markets close in 4 hrs 54 mins

DiaMedica Therapeutics Inc. (DMAC)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
5.42+0.12 (+2.26%)
As of 11:05AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close5.30
Open5.39
Bid5.40 x 1100
Ask5.42 x 800
Day's Range5.37 - 5.49
52 Week Range1.70 - 8.80
Volume16,713
Avg. Volume92,001
Market Cap76.634M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.77
Earnings DateAug. 12, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • DiaMedica Provides a Business Update and Second Quarter 2020 Financial Results
    Business Wire

    DiaMedica Provides a Business Update and Second Quarter 2020 Financial Results

    DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for kidney diseases and neurological disorders, today provided a business update and financial results for the three and six months ended June 30, 2020. DiaMedica will host a conference call tomorrow, August 12, 2020, at 7:00 a.m. Central Time to discuss its business update and second quarter financial results.

  • DiaMedica Announces Closing of $23 Million Public Offering of Common Shares
    Business Wire

    DiaMedica Announces Closing of $23 Million Public Offering of Common Shares

    DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biotechnology company, announced today the closing of its previously announced underwritten registered public offering of 4,600,000 of its common shares, including 600,000 shares sold upon full exercise of the underwriters’ option to purchase additional shares, at a price to the public of $5.00 per share, primarily with institutional investors including several specialist biotech funds and certain existing shareholders.

  • DiaMedica Therapeutics to Report Second Quarter 2020 Financials and Provide a Business Update August 12, 2020
    Business Wire

    DiaMedica Therapeutics to Report Second Quarter 2020 Financials and Provide a Business Update August 12, 2020

    DiaMedica Therapeutics Inc. (Nasdaq: DMAC) today announced that its second quarter 2020 financial results will be released after the markets close on Tuesday, August 11th. DiaMedica will host a live conference call on Wednesday, August 12th at 7:00 AM Central Time to discuss its business update and financial results.